跳至主要内容
临床试验/EUCTR2014-002228-28-IT
EUCTR2014-002228-28-IT进行中(未招募)1 期

A double blind, placebo controlled, parallel groups, multicenter study on filgrastim in amyotrophic lateral sclerosis - STEMALS-II

niversità degli Studi di Torino e Azienda Ospedaliera Città della Salute e della Scienza di Torino0 个研究点目标入组 90 人开始时间: 2014年6月12日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • a. patients with definite, probable, probable laboratory-supported or possible ALS
  • b. age 20-75 years;
  • c. disease duration <=24 months;
  • d. respiratory function (FVC) = 65% of expected;
  • e. patients must understand and accept the protocol requirements, and must give a written informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 90
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 90

排除标准

  • a. previous polio infection ;
  • b. motor neuron diseases other than ALS (progressive bulbar palsy , progressive muscular atrophy , primary lateral sclerosis );
  • c. clinical involvement of other neurological systems (sensory, extrapyramidal , oculomotor, cerebellar);
  • d. serious clinical conditions such as cardiovascular disease, uncontrolled hypertension, renal or hepatic impairment , dysthyroidism , Respiratory Distress Syndrome (ARDS) , sickle-cell anaemia;
  • e. subjects who have participated in any drug trial within 12 weeks prior to recruitment;
  • f . concomitant malignancy, present or past, with the exception of different melanoma skin cancers and carcinoma in situ of the cervix;
  • g . patients with severe congenital neutropaenia syndrome with abnormal cytogenetics;
  • h . patients with rare hereditary problems of fructose intolerance;
  • i . present or past malignant myeloproliferative diseases, secondary polycythemia, splenomegaly with a diameter> 14 cm, thrombophilia was found;
  • j . presence of percutaneous gastrostomy at the time of recruitment ;
  • k . presence of NIV at the time of recruitment;
  • l. subjects who have participated in any drug trial within 12 weeks prior to recruitment;
  • n . drug addiction , alcoholism, or psychiatric disorders;
  • o . women who are pregnant or breastfeeding.

研究者

发起方
niversità degli Studi di Torino e Azienda Ospedaliera Città della Salute e della Scienza di Torino

相似试验